🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
General Note: throughout this record, "Rebif® New Formulation" is used for ...
Status
Completed
Location
Multiple Locations
Start Date
2006-12
Trial ID
NCT00441103
Treatments Being Tested
The goal of this study was to evaluate the safety, tolerability and effecti...
Status
Completed
Location
Research Site
Start Date
2006-11-30
Trial ID
NCT00436826
Treatments Being Tested
The primary objective of the study is to compare the immunogenicity of the ...
Status
Completed
Location
Local US Medical Information
Start Date
2005-01
Trial ID
NCT00110396
Treatments Being Tested
A randomized, double-blind, clinical trial to assess the safety and efficac...
Status
Completed
Location
Hope Research Institute Medical Plaza LLC Desert Hills
Start Date
2008-12-31
Trial ID
NCT00725985
Treatments Being Tested
To evaluate the tolerability of a new formulation of rebif and Betaseron in...
Status
Completed
Location
EMD Serono Med Info
Start Date
2006-12
Trial ID
NCT00428584
Treatments Being Tested
REFLEXION is a double blind extension of the study 27025 (NCT00404352) (REF...
Status
Completed
Location
Research Site
Start Date
2008-12
Trial ID
NCT00813709
The Electronic Device - The RebiSmart™ is an electronic injection device th...
Status
Completed
Location
US Local Medical Information
Start Date
2008-07
Trial ID
NCT00735007
Treatments Being Tested
To evaluate the impact on Quality of Life (QOL), tolerability, treatment sa...
Status
Completed
Location
EMD Serono, Inc.
Start Date
2007-04
Trial ID
NCT00472797
Treatments Being Tested